+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 16Years +
All Genders
ID06623890

Long-Term Safety Study of Omaveloxolone BIIB141 in People With Friedreichs Ataxia Prescribed by Their Doctors

Led by Biogen · Updated on 2026-04-28

300

Participants Needed

14

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the long-term safety of a drug called BIIB141, also known as omaveloxolone or SKYCLARYS4, in people with Friedreichs Ataxia FA. This observational study collects health information from participants without changing their medical care. It involves participants from the Friedreichs Ataxia Global Clinical Consortium FA GCC UNIFIED Natural History Study UNIFAI to better understand how FA affects patients and to monitor safety events related to the drug. Participants are divided into two groups those who will start omaveloxolone treatment as prescribed by their doctors during the study, and those who have started treatment less than 12 months before joining. Participants will be followed for up to 5 years. Doctors will decide how often participants visit based on clinical judgment and drug labeling. Data will be collected at multiple time points, including 1, 2, 3, 6, 12, 24, 36, 48, and 60 months. During the study, researchers will monitor serious adverse events, including heart failure and liver damage related to the drug. They will also track reasons for stopping treatment, leaving the study, or taking more of the drug than prescribed. Participants remain under their own doctors care, and health data from regular visits will be collected throughout the study period.

CONDITIONS

Brief Title

A Study to Learn More About the Long-Term Safety of BIIB141 (Omaveloxolone) in Participants With Friedreich's Ataxia Who Are Prescribed it by Their Own Doctors

Research Team

S

Study Director

G

Global Biogen Clinical Trial Center

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here